<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03633097</url>
  </required_header>
  <id_info>
    <org_study_id>ISEE_2018_TKA_A</org_study_id>
    <nct_id>NCT03633097</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement</brief_title>
  <official_title>Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement - Single-center, Pragmatic, Randomized, Assessor Blinded, Pilot Study-</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Oriental Medical Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korea Health Industry Development Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gachon University Gil Oriental Medical Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 30, 2018</start_date>
  <completion_date type="Actual">May 30, 2021</completion_date>
  <primary_completion_date type="Actual">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>single blinded, outcome assessor blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Korean version of Western Ontario and McMaster Universities Arthritis Index</measure>
    <time_frame>Screening, day 11, day 21</time_frame>
    <description>K-WOMAC is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Numeric rating scale</measure>
    <time_frame>Screening, baseline, day 5, 11, 21, 28, 84</time_frame>
    <description>NRS range was 0-10 with 0 being no pain and 10 the worst pain possible.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Physical Condition related with mobility at every visit</measure>
    <time_frame>Screening, day 11, day 84</time_frame>
    <description>mobility (5 meters walking test at comfortable speed - 5mWT) (meters/second)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Physical Condition related with endurance at every visit</measure>
    <time_frame>Screening, day 11, day 84</time_frame>
    <description>endurance (Sit-to-stand test - STS) (seconds)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Timed Up and Go Test at every visit</measure>
    <time_frame>Screening, day 11, day 84</time_frame>
    <description>a functional test evaluating the time to rise from a chair, walk 3 meters, turn around, walk back to the chair and sit down (abnormal cut-off value &gt;12 seconds).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Alternative-Step Test at every visit</measure>
    <time_frame>Screening, day 11, day 84</time_frame>
    <description>a functional test measuring clinical balance performance, and it has been shown to predict fall risk among elderly subjects (seconds)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Range of motion</measure>
    <time_frame>Screening, baseline, day 5, 11, 28, 84</time_frame>
    <description>Compare flexion and extension angle using long arm goniometer between experimental and comparator group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Knee Replacement</condition>
  <condition>Acupuncture</condition>
  <arm_group>
    <arm_group_label>Acupuncture + Usual care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acupuncture with Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture and Usual care</intervention_name>
    <description>patients after surgery receive usual care(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet) as well as acupuncture treatment as an adjunctive therapy</description>
    <arm_group_label>Acupuncture + Usual care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>patients after surgery receive usual care alone(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet)</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has a diagnosis of osteoarthritis and listed for an unilateral total knee&#xD;
             replacement.&#xD;
&#xD;
          -  Subject has a normal cognitive function&#xD;
&#xD;
          -  Subject is willing and able to give informed consent for participation in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those who have undergone total knee arthroplasty due to gout&#xD;
&#xD;
          -  Those who have had total knee arthroplasty due to trauma&#xD;
&#xD;
          -  Those who have had total knee arthroplasty due to autoimmune related diseases such as&#xD;
             rheumatoid arthritis&#xD;
&#xD;
          -  Those who are participating in other clinical trials&#xD;
&#xD;
          -  Those who have a history of participating in other clinical trials within one month&#xD;
&#xD;
          -  Those who are difficult to write a research consent form&#xD;
&#xD;
          -  Those who are judged to be inappropriate for the clinical study by the researchers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yun Kyung Song, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gachon university of Gil oriental hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Catholic Kwandong University International St. Mary'S Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>22711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic Kwandong University International St. Mary'S Hospita</name>
      <address>
        <city>Incheon</city>
        <zip>22761</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 31, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2018</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University Gil Oriental Medical Hospital</investigator_affiliation>
    <investigator_full_name>Yun-Kyung Song</investigator_full_name>
    <investigator_title>Sponsor-principle investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

